What Has Driven the Growth of the Veterinary Vaccines Market in Recent Years?
The veterinary vaccines market has seen considerable growth due to a variety of factors.
• In the past few years, the veterinary vaccines market has experienced robust growth. The market, which stood at $13.56 billion in 2024, is forecasted to increase to $14.52 billion in 2025, with a compound annual growth rate (CAGR) of 7.1%.
Several factors are driving this historic growth, encompassing the expansion of emerging markets, increased expenditure on pets, a rise in disease prevalence, heightened outbreaks of poultry diseases, and an escalation in zoonotic disease incidents.
What Is The Expected Growth In The Veterinary Vaccines Market Size?
The veterinary vaccines market is expected to maintain its strong growth trajectory in upcoming years.
• The projection for the veterinary vaccines market size indicates substantial growth in the coming years, with an expected value of $19.4 billion by 2029, reflecting a compound annual growth rate (CAGR) of 7.5%.
This anticipated growth during the forecast period is ascribed to factors such as economic growth, the growing adoption of pet insurance, an increase in pet ownership, enhanced government initiatives, and a heightened consciousness concerning animal health. Key trends during this period are projected to include investments in the development of nanoparticles, an amplified production of subunit and virus-like particle-based vaccines, the manufacturing of vaccines like parvovirus, distemper, and adenovirus to satisfy the compulsory and regular vaccination schedules of pet owners, increased spending on technological advancements, higher investments in toxoid vaccines, focus on escalated investments in mRNA vaccines, and strategic collaborations and partnerships.
What Main Forces Are Fueling Expansion In The Veterinary Vaccines Market?
The escalating number of animals affected by a myriad of diseases is heightening the need for vaccines to counter and cure such diseases, subsequently fuelling the veterinary vaccines market. As per the statistics from a study by the Animal and Plant Health Agency, a total of 3289 new TB herd incidents were identified in England. Bovine tuberculosis is a persistent ailment primarily impacting cattle, although it can affect all mammals, resulting in a general state of sickness, coughing, and eventually leading to death. Nevertheless, the ailment is treatable with specified antibiotics that annihilate the TB bacteria. The growing incidence of diseases in animals is projected to spur the veterinary vaccines market throughout the forecast period.
What Are The Primary Segments In The Global Veterinary Vaccines Market?
The veterinary vaccines market covered in this report is segmented –
1) By Application: Livestock Vaccines, Companion Animal Vaccines
2) By Vaccine Type: Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types
3) By Disease Type: Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)
Subsegments:
1) By Livestock Vaccines: Bovine Vaccines, Poultry Vaccines, Porcine Vaccines, Small Ruminant Vaccines (Sheep and Goats), Aquaculture Vaccines
2) By Companion Animal Vaccines: Canine Vaccines, Feline Vaccines, Equine Vaccines
Pre-Book The Veterinary Vaccines Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Key Trends Are Driving Changes In The Veterinary Vaccines Market?
The veterinary vaccines market is witnessing a surge in strategic alliances and collaborations as companies seek to penetrate new regions and jointly work on research and development ventures. An instance of this was observed in February 2022, when Merck Animal Health, a pharmaceutical firm based in the US, entered a four-year strategic partnership with Iowa State University, a research institution also located in the US, to work on progressive solutions for animal healthcare. This alliance covers several areas such as research and development, manufacturing, exploring new technologies, expanding business, and other aspects, all aimed at innovating solutions for addressing animal health issues domestically (US) and globally. In a similar arrangement, MSD Animal Health, a subdivision of Merck & Co with its base in the US, partnered strategically with Vinovo. This tie-up could potentially enhance MSD Animal Health's vaccine offering by integrating its extensive vaccine product range with Vinovo’s vaccine delivery mechanism for a more efficient vaccination process, leading to enhanced bird health and minimized vaccine side effects. Lastly, Wageningen bio-veterinary research entered a strategic collaboration with the Switzerland-based company, Ceva, to bolster their collective research on the worrisome global emergence and reemergence of animal diseases.
Who Are the Key Players in the Veterinary Vaccines Market?
Major companies operating in the veterinary vaccines market include:
• Zoetis Inc.
• Boehringer Ingelheim GmbH
• Merck & Co. Inc.
• Elanco Animal Health Incorporated
• Ceva Santé Animale.
• Virbac Group
• HIPRA
• Biogenesis Bago
• Kyoritsu Seiyaku Corporation
• Phibro Animal Health Corporation
• Century Vaccines Limited
• Bayer Animal Health
• Cadila Vaccines Ltd.
• Cargill India Pvt. Ltd.
• China Animal Healthcare Ltd.
• Jurox Pty Ltd
• Nimrod Veterinary Products Ltd.
• Bimeda
• Animalcare
• MSD Animal Health
• Interfeed
• Biotex Plus Ltd.
• Belfarmacom
• IDT Biologika
• UCBVET
• Lemavet
• Syntec
• Sauvet
• Vetanco
• Chemo Argentina
• Brouwer
• Agrovet Market Animal Health
• DBK Pharma S.A.E.
What Is The Most Dominant Region In The Veterinary Vaccines Market?
North America was the largest region in the veterinary vaccines market in 2024. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in the veterinary vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
